Clinicopathological characteristics and prognostic analysis of Lauren classification in gastric adenocarcinoma in China

Journal of Translational Medicine

Volumn 11, Issue 1, 2013, Pages

  Qiu, Miao Zhen ^a   Cai, Mu Yan ^a   Zhang, Dong Sheng ^a   Wang, Zhi Qiang ^a   Wang, De Shen ^a   Li, Yu Hong ^a   Xu, Rui Hua ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Gastric cancer; Lauren classification; Prognostic analysis

Indexed keywords

CAPECITABINE; DOCETAXEL; FLUOROURACIL; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; IRINOTECAN; OXALIPLATIN; PACLITAXEL;

ADJUVANT THERAPY; ADULT; AGE; ARTICLE; CANCER CLASSIFICATION; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CHINA; CLINICAL FEATURE; FEMALE; GASTRECTOMY; HUMAN; LAUREN CLASSIFICATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; SEX DIFFERENCE; STOMACH ADENOCARCINOMA; TUMOR LOCALIZATION; TUMOR VOLUME;

ADENOCARCINOMA; CHINA; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; STOMACH NEOPLASMS;

EID: 84874543987     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-11-58     Document Type: Article

References (25)

1. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006, 24:2137-50. 10.1200/JCO.2005.05.2308, 16682732.
2. Moore MA, Eser S, Igisinov N, Igisinov S, Mohagheghi MA, Mousavi-Jarrahi A, Ozentürk G, Soipova M, Tuncer M, Sobue T. Cancer epidemiology and control in North-Western and Central Asia - past, present and future. Asian Pac J Cancer Prev 2010, 11:17-32.
3. Lauren P. The two histologic main types of gastric carcinoma: diffuse and so-called intestinal type carcinoma. An attempt at a histo-clinical classification. Acta Parhol Microbid Scan 1965, 64:31-49.
4. Vauhkonen M, Vauhkonen H, Sipponen P. Pathology and molecular biology of gastric cancer. Best Pract Res Clin Gastroenterol 2006, 20:651-674. 10.1016/j.bpg.2006.03.016, 16997151.
5. Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, Lordick F, Ohtsu A, Omuro Y, Satoh T, Aprile G, Kulikov E, Hill J, Lehle M, Rüschoff J, Kang YK, ToGA Trial Investigators Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2 positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomized controlled trial. Lancet 2010, 376:687-697. 10.1016/S0140-6736(10)61121-X, 20728210, ToGA Trial Investigators.
6. Van Cutsem E, Moiseyenko VM, Tjulandin S, Majlis A, Constenla M, Boni C, Rodrigues A, Fodor M, Chao Y, Voznyi E, Risse ML, Ajani JA, V325 Study Group Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group. J Clin Oncol 2006, 24:4991-4997. 10.1200/JCO.2006.06.8429, 17075117, V325 Study Group.
7. Tanner M, Hollmén M, Junttila TT, Kapanen AI, Tommola S, Soini Y, Helin H, Salo J, Joensuu H, Sihvo E, Elenius K, Isola J. Amplification of HER-2 in gastric carcinoma: association with Topoisomerase II alpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab. Ann Oncol 2005, 16:273-278. 10.1093/annonc/mdi064, 15668283.
8. Yamashita K, Sakuramoto S, Katada N, Futawatari N, Moriya H, Hirai K, Kikuchi S, Watanabe M. Diffuse type advanced gastric cancer showing dismal prognosis is characterized by deeper invasion and emerging peritoneal cancer cell: the latest comparative study to intestinal advanced gastric cancer. Hepatogastroenterology 2009, 56:276-281.
9. Miyahara R, Niwa Y, Matsuura T, Maeda O, Ando T, Ohmiya N, Itoh A, Hirooka Y, Goto H. Prevalence and prognosis of gastric cancer detected by screening in a large Japanese population: data from a single institute over 30 years. J Gastroenterol Hepatol 2007, 22:1435-1442. 10.1111/j.1440-1746.2007.04991.x, 17573829.
10. Zheng H, Takahashi H, Murai Y, Cui Z, Nomoto K, Miwa S, Tsuneyama K, Takano Y. Pathobiological characteristics of intestinal and diffuse-type gastric carcinoma in Japan: an immunostaining study on the tissue microarray. J Clin Pathol 2007, 60:273-277. 1860577, 16714395.
11. Japanese Gastric Cancer Association Japanese classification of gastric carcinoma-2nd English edition. Gastric Cancer 1998, 1:10-24. Japanese Gastric Cancer Association.
12. Correa P, Cuello C, Duque E. Carcinoma and intestinal metaplasia of the stomach in Colombian migrants. J Natl Cancer Inst 1970, 44:297-306.
13. Muñoz N, Correa P, Cuello C, Duque E. Histologic types of gastric carcinoma in high- and low-risk areas. Int J Cancer 1968, 3:809-818. 10.1002/ijc.2910030614, 5731983.
14. Stalsberg H. Histological typing of gastric carcinoma. A comparison of surgical and autopsy materials, and of primary tumours and metastases. Acta Pathol Microbiol Scand A 1972, 80:509-514.
15. Kim KH, Chi CH, Lee SK, Lee D, Kubo T. Histologic types of gastric carcinoma among Koreans. Cancer 1972, 29:1261-1263. 10.1002/1097-0142(197205)29:5<1261::AID-CNCR2820290519>3.0.CO;2-M, 4336630.
16. Stemmermann GN, Brown C. A survival study of intestinal and diffuse types of gastric carcinoma. A survival study of intestinal and diffuse types of gastric carcinoma. Cancer 1974, 33:1190-1195. 10.1002/1097-0142(197404)33:4<1190::AID-CNCR2820330444>3.0.CO;2-L, 4362106.
17. Qiu MZ, Wang ZQ, Luo HY, Zhang DS, Zhou ZW, Li YH, Jiang WQ, Xu RH. Prognostic analysis in node-negative gastric cancer patients in China. Tumour Biol 2011, 32:489-492. 10.1007/s13277-010-0142-5, 21181465.
18. Förster S, Gretschel S, Jöns T, Yashiro M, Kemmner W. THBS4, a novel stromal molecule of diffuse-type gastric adenocarcinomas, identified by transcriptome-wide expression profiling. Mod Pathol 2011, 24:1390-1403. 10.1038/modpathol.2011.99, 21701537.
19. Qiu MZ, Wang ZQ, Zhang DS, Liu Q, Luo HY, Zhou ZW, Li YH, Jiang WQ, Xu RH. Comparison of 6th and 7th AJCC TNM staging classification for carcinoma of the stomach in China. Ann Surg Oncol 2011, 18:1869-1876. 10.1245/s10434-010-1542-x, 21246404.
20. Qiu MZ, Han B, Luo HY, Zhou ZW, Wang ZQ, Wang FH, Li YH, Xu RH. Expressions of hypoxia-inducible factor-1α and hexokinase-II in gastric adenocarcinoma: the impact on prognosis and correlation to clinicopathologic features. Tumour Biol 2011, 32:159-166. 10.1007/s13277-010-0109-6, 20845004.
21. Teh M, Lee Y-S. Intestinal and diffuse carcinoma of the stomach cancer among the ethnic and dialectic groups in Singapore. Cancer 1987, 60:921-925. 10.1002/1097-0142(19870815)60:4<921::AID-CNCR2820600435>3.0.CO;2-Z, 3594411.
22. Ribeiro MM, Sarmento JA, Sobrinho Simões MA, Bastos J. Prognostic significance of Lauren and Ming classifications and other pathologic parameters in gastric carcinoma. Cancer 1981, 47:780-784. 10.1002/1097-0142(19810215)47:4<780::AID-CNCR2820470424>3.0.CO;2-G, 7226025.
23. Yamamoto T, Kato H. Two major histological types of gastric carcinoma among the fixed population of Hiroshima and Nagasaki. Gann 1971, 62:381-387.
24. Qiu MZ, Wang ZQ, Zhang DS, Luo HY, Zhou ZW, Wang FH, Li YH, Jiang WQ, Xu RH. Clinicopathological characteristics and prognostic analysis of gastric cancer in the young adult in China. Tumour Biol 2011, 32:509-514. 10.1007/s13277-010-0145-2, 21181464.
25. Amorosi A, Palli D. Epidemiology of intestinal and diffuse types of gastric carcinoma: a time-trend study in Finland with comparison between studies from high- and low-risk areas. Cancer 1994, 73:1533.